Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
72
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins

Hadi Mirzaei1 Department of Biotechnology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
,
Bahram Kazemi1 Department of Biotechnology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IranCorrespondence[email protected]
,
Mojgan Bandehpour1 Department of Biotechnology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
,
Alireza Shoari2 Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran
,
Vahid Asgary2 Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran
,
Mehdi Shafiee Ardestani3 Department of Radiopharmacy, Pharmacy Faculty, Tehran University of Medical Sciences, Tehran, Iran
,
Armin Madadkar-Sobhani4 Faculty of Science, University of Ontario Institute of Technology, Oshawa, Canada
&
Reza Ahangari Cohan2 Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, IranCorrespondence[email protected]
 show all
Pages 1193-1200 | Published online: 16 Mar 2016

References

  • DebeljakNSytkowskiAJErythropoietin and erythropoiesis stimulating agentsDrug Test Anal201241180581222508651
  • LeeJSHaTKLeeSJLeeGMCurrent state and perspectives on erythropoietin productionAppl Microbiol Biotechnol20129561405141622820523
  • EspositoCAbelliMSilenoGEffects of continuous erythropoietin receptor activator (CERA) in kidney transplant recipientsTransplant Proc20124471916191722974870
  • GonzalezMTRamosRVeraMMonthly CERA treatment maintains stable hemoglobin levels in routine clinical practice of peritoneal dialysis patientsRen Fail201335331431923356501
  • RobertsMJBentleyMDHarrisJMChemistry for peptide and protein PEGylationAdv Drug Deliv Rev200254445947612052709
  • Gaberc-PorekarVZoreIPodobnikBMenartVObstacles and pitfalls in the PEGylation of therapeutic proteinsCurr Opin Drug Discov Devel2008112242250
  • WangY-SYoungsterSGraceMBauschJBordensRWyssDFStructural and biological characterization of pegylated recombinant interferon α-2b and its therapeutic implicationsAdv Drug Deliv Rev200254454757012052714
  • DouHZhangMZhangYYinCSynthesis and purification of mono-PEGylated insulinChem Biol Drug Des200769213213817381727
  • PorowinskaDWujakMRoszekKKomoszynskiMProkaryotic expression systemsPostepy Hig Med Dosw (Online)201367119129 Polish23475488
  • SodoyerRExpression systems for the production of recombinant pharmaceuticalsBioDrugs2004181516214733607
  • CohanRAMadadkar-SobhaniAKhanahmadHDesign, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietinInt J Nanomedicine201161217122721753873
  • Bayram AkcapinarGVenturiniAMartelliPLCasadioRSezermanUOModulating the thermostability of Endoglucanase I from Trichoderma reesei using computational approachesProtein Eng Des Sel201528512713525784767
  • VertesySMichalakMMillerMCStructural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presenceProtein Eng Des Sel201528719921025796447
  • JenkinsNMurphyLTytherRPost-translational modifications of recombinant proteins: significance for biopharmaceuticalsMol Biotechnol200839211311818327554
  • MalekiAMadadkar-SobhaniARoohvandFDesign, modeling, and expression of erythropoietin cysteine analogs in Pichia pastoris: improvement of mean residence times and in vivo activities through cysteine-specific PEGylationEur J Pharm Biopharm201280349950722068050
  • BonoraGMDrioliSReactive PEGs for protein conjugationVeroneseFMPEGylated Protein Drugs: Basic Science and Clinical Applications Milestones in Drug Therapy1st edBasel, SwitzerlandBirkhäuser Basel Publications20093345
  • PasutGVeroneseFMState of the art in PEGylation: the great versatility achieved after forty years of researchJ Control Release2012161246147222094104
  • SamoudiMTabandehFMinuchehrZRational design of hyper-glycosylated interferon beta analogs: a computational strategy for glycoengineeringJ Mol Graph Model201556314225544388
  • WangYJHaoSJLiuYDPEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietinJ Control Release2010145330631320427020
  • JevševarSKunsteljMHalf-life extension through PEGylationKontermannRTherapeutic Proteins: Strategies to Modulate Their Plasma Half-Lives1st edWeinheim, GermanyJohn Wiley & Sons Publications20124156

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.